Back to PCVX

Kynam Capital Management, LP → PCVX

Kynam Capital Management, LP PCVX Position History

Vaxcyte, Inc. • Healthcare

Quarters held
4
Latest value
$148.4M
Q3 2026
Peak value
$169.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$134.8M
Q1 2026$169.8M
Q2 2026$169.9M
Q3 2026$148.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$148.4M2.61M——
Q2 2026$169.9M2.92M——
Q1 2026$169.8M2.92M——
Q4 2025$134.8M2.92M——

Other funds holding PCVX

Other Kynam Capital Management, LP positions

COGT

COGENT BIOSCIENCES INC

$219M
CLDX

CELLDEX THERAPEUTICS INC NEW

$198.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$188.1M
CLDX

CELLDEX THERAPEUTICS INC NEW

$185.3M
LEGN

LEGEND BIOTECH CORP

$182.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$176M
VERA

VERA THERAPEUTICS INC

$173.8M
SNDX

SYNDAX PHARMACEUTICALS INC

$169.2M